Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Not Yet Recruiting NCT06763926

Intranasal Nafarelin For Triggering Oocyte Maturation

Conditions: Fertility Preservation

Sex: Female

Ages: 18 Years – 40 Years

Healthy volunteers: No

Phase: PHASE4

Enrollment: 154

Sponsor: Fundacion Dexeus

Location: Dexeus Mujer Sabadell Sabadell Barcelona

Summary

This is a non-inferiority randomised, controlled clinical trial comparing subcutaneous triptorelin to intranasal nafarelin for the final maturation of oocytes in women undergoing fertility preservation cycles with oocyte cryopreservation undergoing ovarian stimulation.

Eligibility Criteria

Inclusion Criteria: * Women undergoing fertility preservation cycles with oocyte cryopreservation * Undergoing a progesterone-primed ovarian stimulation cycle (PPOS) with any commercially available gonadotropin preparation(s) * BMI 18 - 30 kg/m2 Exclusion Criteria: * Allergy or hypersensitivity to either of the study drugs * Hypopituitarism * Known pituitary tumour * Contraindication to intranasal medication administration * Previous poor response to agonist trigger

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06763926). StuddyBuddy aggregates publicly available trial information.